Article
The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment - 1 Jan 2013
Mazzola Emanuele, Cheng Su-Chun, Parmigiani Giovanni
Abstract excerpt
Ductal carcinoma in situ (DCIS) is a precancerous lesion of the female breast and is strongly suspected to be a precursor of invasive breast cancer (IBC). Our goal is the estimation of the age-specific and lifetime penetrances of DCIS among carriers of either a BRCA1 or BRCA2 deleterious mutation. We jointly re-analyze the SEER9 database and a previous study by Claus et al. (JAMA 293:964-969, 2005). Estimation is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
